Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU)

NCT01853384 is registered in ClinicalTrials.gov with Healthpoint as lead sponsor.

NCT NCT01853384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01853384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU)
Lead sponsor
Healthpoint
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2013
Completion date
February 28, 2015
Enrollment
252 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

ulcer, venous stasis ulcer, venous ulcer